Abstract
Components of the adipose renin-angiotensin system (RAS) have been suggested as providing a potential pathway linking obesity to hypertension. In adipose cells, the biological responses to β-adrenergic stimulation are mediated by an increase in intracellular cAMP. Because an association exists among body fat mass, hypertension, and increased sympathetic stimulation, we examined the influence of cAMP on angiotensinogen (ATG) expression and secretion in human adipose tissue and in parallel we studied the DNA binding activity of CRE transcriptional factors. A 24 h exposure to the cAMP analog 8Br-cAMP resulted in significant increases in ATG mRNA levels (+176 ±60%) and protein secretion (+40 ±27%). The ability of 8Br-cAMP to promote ATG gene expression was unaltered by H89, a protein kinase A inhibitor, because H89 perse was found to stimulate ATG mRNA levels and protein secretion. Moreover, 8Br-cAMP stimulated the specific CRE DNA binding activity (+115 ±14%) in human adipocyte nuclear extracts as assessed by electrophoretic mobility shift assays. These results indicate that cAMP upregulates in vitro ATG expression and secretion in human adipose tissue and that the induction in ATG mRNA levels appears to result, at least in part, from positive effects on the DNA binding activity of CRE transcription factors. Further studies are required to determine whether this regulatory pathway is activated in human obesity and to elucidate the importance of adipose ATG to the elevated blood pressure observed in this pathological state.
Similar content being viewed by others
References
Kissebah, A. H. and Krakower, G. R. (1994). Physiol. Rev. 74, 761–811.
Bjorntorp, P. (1997). Lancet 350, 423–426.
Ailhaud, G. (2000). Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S1–3.
Saye, J. A., Ragsdale, N. V., Carey, R. M., and Peach, M. J. (1993). Am. J. Physiol. 264, C1570–1576.
Pinterova, L., Krizanova, O., and Zorad, S. (2000). Gen. Physiol. Biophys. 19, 329–334.
Engeli, S., Gorzelniak, K., Kreutz, R., Runkel, N., Distler, A., and Sharma, A. M. (1999). J. Hypertens. 17, 555–560.
Phillips, M. I., Speakman, E. A., and Kimura, B. (1993). Regul. Pept. 43, 1–20.
Reid, I. A., Morris, B. J., and Ganong, W. F. (1978). Annu. Rev. Physiol. 40, 377–410.
Darimont, C., Vassaux, G., Ailhaud, G., and Negrel, R. (1994). Endocrinology 135, 2030–2036.
Saint-Marc, P., Kozak, L. P., Ailhaud, G., Darimont, C., and Negrel, R. (2001). Endocrinology 142, 487–492.
Jones, B. H., Standridge, M. K., and Moustaid, N. (1997). Endocrinology 138, 1512–1519.
Frederich, R. C., Jr., Kahn, B. B., Peach, M. J., and Flier, J. S. (1992). Hypertension 19, 339–344.
Tamura, K., Umemura, S., Nyui, N., et al. (1996). Hypertension 27, 1216–1223.
Massiera, F., Bloch-Faure, M., Ceiler, D., et al. (2001). FASEB J. 15, 2727–2729.
Faloia, E., Giacchetti, G., and Mantero, F. (2000). J. Endocrinol. Invest. 23, 54–62.
Umemura, S., Nyui, N., Tamura, K., et al. (1997). Am. J. Hypertens. 10, 629–633.
Engeli, S., Negrel, R., and Sharma, A. M. (2000). Hypertension 35, 1270–1277.
Berglund, G. and Andersson, O. (1981). Int. J. Obes. 5(Suppl 1), 143–150.
Rodbell, M. (1964). J. Biol. Chem. 239, 375–380.
Narayanan, C. S., Cui, Y., Kumar, S., and Kumar, A. (2000). Mol. Cell. Biochem. 212, 81–90.
Serazin, V., Dieudonne, M. N., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2004). Am. J. Physiol. Endocrinol. Metab. 286, E434–438.
Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., and Sharma, A. M. (2002). Diabetes 51, 1699–1707.
Aubert, J., Darimont, C., Safonova, I., Ailhaud, G., and Negrel, R. (1997). Biochem. J. 328(Pt 2), 701–706.
Yang, S., Fang, Z., Suzuki, T., et al. (2002). J. Clin. Endocrinol. Metab. 87, 2336–2345.
Wang, T. T., Chen, M., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1994). Kidney Int. 46, 703–710.
Coezy, E. D., Corvol, P., and Howlett, A. C. (1990). Cell Signal. 2, 67–76.
Klett, C., Nobiling, R., Gierschik, P., and Hackenthal, E. (1993). J. Biol. Chem. 268, 25095–25107.
Jones, B. H., Standridge, M. K., Taylor, J. W., and Moustaid, N. (1997). Am. J. Physiol. 273, R236–242.
Ming, M., Wang, T. T., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1995). Am. J. Physiol. 268, R105–111.
Ohtani, R., Yayama, K., Takano, M., Itoh, N., and Okamoto, H. (1992). Endocrinology 130, 1331–1338.
Nielsen, D. A. and Shapiro, D. J. (1990). Mol. Endocrinol. 4, 953–957.
Gillis, P. and Malter, J. S. (1991). J. Biol. Chem. 266, 3172–3177.
Malter, J. S. and Hong, Y. (1991). J. Biol. Chem. 266, 3167–3171.
Fimia, G. M., De Cesare, D., and Sassone-Corsi, P. (1999). Nature 398, 165–169.
Anderson, E. A., Sinkey, C. A., Lawton, W. J., and Mark, A. L. (1989). Hypertension 14, 177–183.
Kannel, W. B., Brand, N., Skinner, J. J., Jr., Dawber, T. R., and McNamara, P. M. (1967). Ann. Intern. Med. 67, 48–59.
Eliahou, H. E., Iaina, A., Gaon, T., Shochat, J., and Modan, M. (1981). Int. J. Obes. 5(Suppl 1), 157–163.
Caulfield, M., Lavender, P., Newell-Price, J., Kamdar, S., Farrall, M., and Clark, A. J. (1996). Hypertension 28, 1123–1125.
Nyui, N., Tamura, K., Yamaguchi, S., et al. (1997). Hypertension 30, 859–867.
Cooper, R., McFarlane-Anderson, N., Bennett, F. I., et al. (1997). J. Hum. Hypertens. 11, 107–111.
Cooper, R., Forrester, T., Ogunbiyi, O., and Muffinda, J. (1998). J. Hypertens. 16, 571–575.
Van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S., and Arner, P. (2000). Obes. Res. 8, 337–341.
Hainault, I., Nebout, G., Turban, S., Ardouin, B., Ferre, P., and Quignard-Boulange, A. (2002). Am. J. Physiol. Endocrinol. Metab. 282, E59–66.
Giacchetti, G., Faloia, E., Sardu, C., et al. (2000). Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S142–143.
Faloia, E., Gatti, C., Camilloni, M. A., et al. (2002). J. Endocrinol. Invest. 25, 309–314.
Gorzelniak, K., Engeli, S., Janke, J., Luft, F. C., and Sharma, A. M. (2002). J. Hypertens. 20, 965–973.
Chomczynski, P. and Sacchi, N. (1987). Anal. Biochem. 162, 156–159.
Serazin-Leroy, V., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2000). Am. J. Physiol. Endocrinol. Metab. 279, E1398–1405.
Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. (1997). J. Clin. Endocrinol. Metab. 82, 2371–2374.
Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Nucleic Acids Res. 11, 1475–1489.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serazin, V., Santos, E.D., Morot, M. et al. Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity. Endocr 25, 97–103 (2004). https://doi.org/10.1385/ENDO:25:2:097
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:25:2:097